We’re excited to announce that Alan Jones has joined the company as our new Vice President of Business Development. Jones – who has deep experience in establishing long-term client relationships across design, construction, manufacturing and other industries – will report to Lance Nordbak, CRB’s Chief Operating Officer for Regional Operations.
Grand River Aseptic Manufacturing’s (“GRAM”) state-of-the-art, large-scale fill/finish facility, designed and constructed in collaboration with CRB has been named a 2021 Facility of the Year Award winner by the International Society for Pharmaceutical Engineering.
New Technical and Design & Construction operations teams will drive innovation, excellence in execution, and technical service to create client value across the project lifecycle and facility operations
The plant-based food market sees a demand surge as consumers seek out new and novel products. Producers are partnering with firms like CRB to design and build research and production facilities that will adapt and grow as the segment’s products evolve.
CRB is proud to announce that the Amicus Therapeutics Research and Gene Therapy Center facility has won Engineering News-Record (ENR) MidAtlantic’s 2020 Best Projects (Award of Merit) in the Healthcare category.
Tom Rychlewski leverages CRB’s expertise for companies considering entry into the plant-based protein segment in Food Engineering‘s “Plant-based protein market offers potential for product, processing innovation.”
Mark Paskanik, AIA, NCARB will lead a webinar on “Innovative Science with Less and the Lab Future” at the Lab Design Digital Summit. Taking place May 11-13, this digital summit will feature a series of informative webinars that will bring together lab management leaders with experts in the laboratory and healthcare design community.
As the food and beverage market shifts to a new way of working amid COVID-19, manufacturers remain hopeful for 2020. Jason Robertson joins Food Processing to recap industry figures for 2019 and share forward-facing food and forward-facing challenges in “2020 Capital Spending Outlook: Getting to Yes on Capital Projects.”
Vaccines and therapies can’t come soon enough for a world desperate to limit or erase the threat of COVID-19. But there’s good news from an industry long accustomed to a speed-to-market mentality: Pharmaceutical companies are fully engaged.
CRB is a proud sponsor of the 2020 ISPE Aseptic Conference which will focus on providing flexible and reliable solutions for the implementation and management of the latest in aseptic, barrier, containment, and aseptic best practice technologies, including automated visual inspections.
Allan Bream, Bioprocess Specialist at CRB, was recently featured in Pharma’s Almanac, with an article entitled, “Isolator Design in Cell Therapy Facilities.”
Cell and gene therapy manufacturing must be performed under aseptic conditions and with good aseptic handling practices to ensure patient safety. The use of isolators can help address this critical need, but designing isolators for advanced therapy medicinal product (ATMP) processes can be challenging.
Noel Maestre, PE and Emily Thompson, PE will be conducting a webinar via Cell and Gene Therapy Insights on how to deliver multi-product or multimodal Advanced Therapy Medicinal Product (ATMP) facilities to adapt to an evolving product pipeline.
Supporting our recent project growth in southern California, CRB is pleased to announce we’ve opened a new office in Tustin, Calif. The location will allow us to attract the best talent in the southern California region, pursue new business in Orange County and assist new and ongoing projects affiliated with its office in El Segundo, Calif.
CRB’s David B. Korzuch Jr., PE; and Christopher J. Barbieri, PE detailed several energy-saving strategies that can be implemented into the HVAC system design of a pharmaceutical-grade clean room suite in Consulting Specifying Engineer (CSE).
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.